NCIt definition : An oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R)
and insulin receptor (InsR) tyrosine kinases with potential antineoplastic activity.
Dual IGF-IR/InsR inhibitor BMS-754807 binds reversibly to and inhibits the activities
of IGF-1R and InsR, which may result in the inhibition of tumor cell proliferation
and the induction of tumor cell apoptosis. IGF-1R and InsR tyrosine kinases, overexpressed
in a variety of human cancers, play significant roles in mitogenesis, angiogenesis,
and tumor cell survival.;
UNII : W9E3353E8J;
InChIKey : LQVXSNNAFNGRAH-QHCPKHFHSA-N;
CAS number : 1001350-96-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1001350-96-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;